MORPHINE SULPHATE 10MG/ML INJECTION

Kraj: Cypr

Język: grecki

Źródło: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

Składnik aktywny:

MORPHINE SULFATE

Dostępny od:

MARTINDALE PHARMACEUTICALS LTD (0000003314) BAMPTON ROAD, HAROLD HILL, ROMFORD, RM3 8UG

Kod ATC:

N02AA01

INN (International Nazwa):

MORPHINE

Dawkowanie:

10MG/ML

Forma farmaceutyczna:

INJECTION

Skład:

MORPHINE SULFATE (0000064313) 10MG

Droga podania:

INTRAMUSCULAR USE; INTRAVENOUS USE; ΥΠΟΔΟΡΙΑ ΧΡΗΣΗ

Typ recepty:

Εθνική Διαδικασία

Dziedzina terapeutyczna:

MORPHINE

Podsumowanie produktu:

Νομικό καθεστώς: Με Ιατρική Συνταγή σύμφωνα με την Περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νομοθεσία; 10 AMPS X1ML (200045801) 10 AMPOULE - Εγκεκριμένο - Με Ιατρική Συνταγή σύμφωνα με την Περί Ναρκωτικών Φαρμάκων και Ψυχοτρόπων Ουσιών Νομοθεσία

Ulotka dla pacjenta

PACKAGE LEAFLET: INFORMATION FOR THE USER
Morphine Sulfate Injecton BP 10mg/ml, 15mg/ml, 20mg/ml & 30mg/ml
Morphine Sulfate
READ THIS LEAFET CAREFULLY BEEFRRE YRU ARE GIVEN THIS MEDICINE(

Keep this leafet you may need to read it again

If you have any further questons, please ask your doctor or nurse.

If any of the side efects gets serious, or if you notce any side
efects not listed in this leafet
please tell your doctor or nurse.
IN THIS LEAFET:
1.
What Morphine Sulfate Injecton is and what it is used for
2.
Before you are given Morphine Sulfate Injecton
3.
How Morphine Sulfate Injecton will be given
4.
Possible side efects
5.
How to store Morphine Sulfate Injecton
6.
Further informaton
1(
WHAT MRRPHINE SULFATE INJECTRN IS AND WHAT IT IS USED FRR
Morphine is an alkaloid with powerful pain relieving propertes.
This medicine is used for the relief of severe pain.
2(
BEFRRE YRU ARE GIVEN MRRPHINE SULFATE INJECTRN
You should not be given Morphine Sulfate Injecton iff

you are allergic (hypersensitvee to Morphine or any of the ingredients
listed in secton 6 of
this leafet

you are currently taking drugs used to treat depression known as
monoamine oxidase
inhibitors (MAOIse or have taken them in the last 2 weeks

you sufer from breathing difcultes (asthma or chronic obstructve
airways diseasee

you have sufered a head injury

you sufer from alcoholism

you sufer from heart problems

you are sufering from stomach pains

you are sufering from a tumour of the adrenal gland known as
phaeochromocytoma

you are pregnant or breast-feeding

your child has a liver or kidney problem.
TAKE SPECIAL CARE WITH MRRPHINE SULFATE INJECTRN IF:

you sufer from low blood pressure

you sufer from underactve thyroid

you sufer from problems with your prostate gland

you sufer from any liver or kidney diseases

you sufer from fts
TAKING RTHER MEDICINES
Please tell your doctor or nurse if you are taking, or have recently
taken, any other medicine
including medicines obtained without pre

Charakterystyka produktu

PRODUCT SUMMARY
1.
NAME OF THE MEDICINAL PRODUCT
Morphine Sulfate Injection BP 10mg in 1ml
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Morphine Sulfate BP 1.0 % w/v
3.
PHARMACEUTICAL FORM
Solution for Injection
4.
CLINICAL PARTICULARS
4.1.
THERAPEUTIC INDICATIONS
For the relief of severe pain.
4.2.
POSOLOGY AND METHOD OF ADMINISTRATION
By intramuscular, subcutaneous or intravenous injection. Adults
Initially 10 - 20mg, the dose may be repeated every 4-6 hours.
In cases of terminal pain higher doses may be required.
The
Elderly
Caution is advised. A reduction of dose is advisable.
Children
Not recommended for children under 1 year old.
i)
Children
1
–
5
years

_For acute/post-operative pain_
By intramuscular or subcutaneous injection: 2.5 – 5mg. The dose may
be repeated every 4
hours if necessary.
By intravenous injection over at least 5 minutes: 100 –
200micrograms/kg repeated every
4 hours if necessary. (see table 1)
By intravenous injection and infusion: initially by intravenous
injection (over at
least 5
minutes) 100-200 micrograms/kg (see table 1) then by continuous
intravenous infusion 20
micrograms/kg/hour adjusted according to response.

_For chronic pain_
By intramuscular or subcutaneous injection: initially 150 – 200
micrograms/kg every 4
hours, adjusted according to response. (see table 2)
ii)
Children 6 - 12 years

_For acute/post-operative pain_
By intramuscular or subcutaneous injection: 5 – 10mg, repeated every
4 hours if
necessary.
By intravenous injection over at least 5 minutes: 100 – 200
micrograms/kg repeated every
4 hours if necessary. (see table 1)
By intravenous injection and infusion: initially by intravenous
injection (over at
least 5
minutes) 100-200 micrograms /kg (see table 1) then by continuous
intravenous infusion 20
micrograms/kg/hour adjusted according to response.

_Chronic pain_
By intramuscular or subcutaneous injection: initially 200
micrograms/kg every 4 hours,
adjusted according to response. (see table 2)
iii)
Children
13
-
17
years

_For acute/post-